Orexigenic effects of a growth hormone secretagogue and nitric oxide in aged rats and dogs: Correlation with the hypothalamic expression of some neuropeptidergic/receptorial effectors mediating food intake

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 61, Issue 4, 2006, Pages 315-322

  Rigamonti, Antonello E ^a   Bonomo, Sara M ^a   Scanniffio, Diego ^a   Cella, Silvano G ^a   Müller, Eugenio E ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APPETITE STIMULANT; EP 51216; GHRELIN; GROWTH HORMONE SECRETAGOGUE; LEPTIN; MESSENGER RNA; MOLSIDOMINE; NEUROPEPTIDE; NITRIC OXIDE DONOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATABOLISM; CONTROLLED STUDY; DOG; ENZYME REGULATION; EVALUATION RESEARCH; FEEDING BEHAVIOR; FEMALE; FOOD INTAKE; GROWTH HORMONE RELEASE; HYPOTHALAMUS FUNCTION; MALE; NEUROCHEMISTRY; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALIA; CANIS FAMILIARIS; MAMMALIA;

EID: 33645959181     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/61.4.315     Document Type: Article

References (59)

1. Clarkston WK, Pantano MM, Morley JE, Horowitz M, Littlefield JM, Burton FR. Evidence for the anorexia of ageing: gastrointestinal transit and hunger in healthy elderly vs. young adults. Am J Physiol. 1997;272:R243-R248.
2. Newman AB, Yanez D, Harris T, Duxbury A, Enright PL, Fried LP. Weight change in old age and its association with mortality. J Am Geriatr Soc. 2001;49:1309-1318.
3. Morley JE. Anorexia in older persons: epidemiology and optimal treatment. Drugs Aging. 1996;8:134-155.
4. Roberts SB, Fuss P, Heyman MB, et al. Control of food intake in older men. JAMA. 1994;272:1601-1606.
5. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev. 1999;20:68-100.
6. Chapman IM. Endocrinology of anorexia of ageing. Best Pract Res Clin Endocrinol Metab. 2004;18:437-452.
7. Gruenewald DA, Marck BT, Matsumoto AM. Fasting-induced increases in food intake and neuropeptide Y gene expression are attenuated in aging male brown Norway rats. Endocrinology. 1996;137:4460-4467.
8. Wolden-Hanson T, Marck BT, Matsumoto AM. Blunted hypothalamic neuropeptide gene expression in response to fasting, but preservation of feeding responses to AgRP in aging male Brown Norway rats. Am J Physiol Regul Integr Comp Physiol. 2004;287:R138-R146.
9. Li H, Matheny M, Tumer N, Scarpace PJ. Aging and fasting regulation of leptin and hypothalamic neuropeptide Y gene expression. Am J Physiol. 1998;275:E405-E411.
10. Scarpace PJ, Tumer N. Peripheral and hypothalamic leptin resistance with age-related obesity. Physiol Behav. 2001;74:721-727.
11. Shek EW, Scarpace PJ. Resistance to the anorexic and thermogenic effects of centrally administrated leptin in obese aged rats. Regul Pept. 2000;92:5-71.
12. Morley JE, Thomas DR. Anorexia and aging: pathophysiology. Nutrition. 1999;15:499-503.
13. Morley JE. Pathophysiology of weight loss in older persons. Nestle Nutr Workshop Ser Clin Perform Programme. 2005;10:167-172.
14. van der Lely AJ, Tschop M, Heiman ML, Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev. 2004;25:426-457.
15. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I. Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology. 2000;141:4797-4800.
16. Gaskin FS, Farr SA, Banks WA, Kumar VB, Morley JE. Ghrelin-induced feeding is dependent on nitric oxide. Peptides. 2003;24:913-918.
17. Rigamonti AE, Cella SG, Cavallera GM, et al. Contrasting effects of nitric oxide on food intake and GH secretion stimulated by a GH-releasing peptide. Eur J Endocrinol. 2001;144:155-162.
18. Rigamonti AE, Bonomo SM, Cella SG, Muller EE. GH and cortisol rebound rise during and following a somatostatin infusion: studies in dogs with the use of a GH-releasing peptide. J Endocrinol. 2002;174:387-394.
19. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000;404:661-671.
20. Morley JE. Anorexia of aging: physiologic and pathologic. Am J Clin Nutr. 1997;66:760-773.
21. Arvat E, Giordano R, Broglio F, et al. GH secretagogues in aging. J Anti-Aging Med. 2000;3:149-158.
22. Broglio F, Benso A, Castiglioni C, et al. The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects. J Clin Endocrinol Metab. 2003;88:1537-1542.
23. Ghigo E, Arvat E, Aimaretti G, Broglio F, Giordano R, Camanni F. Diagnostic and therapeutic uses of growth hormone-releasing substances in adult and elderly subjects. Baillieres Clin Endocrinol Metab. 1998;12:341-358.
24. Müller EE, Locatelli V, Cocchi D. Neuroendocrine control of growth hormone secretion. Physiol Rev. 1999;79:511-607.
25. Englander EW, Gomez GA, Greeley GH Jr. Alterations in stomach ghrelin production and in ghrelin-induced growth hormone secretion in the aged rat. Mech Ageing Dev. 2004;125:871-875.
26. Cowley MA, Smith RG, Diano S, et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron. 2003;37:649-661.
27. Toshinai K, Date Y, Murakami N, et al. Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology. 2003;144:1506-1512.
28. Rigamonti AE, Pincelli AI, Corrá B, et al. Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients. J Endocrinol. 2002;175:R1-R5.
29. Englander EW, Gomez GA, Greeley GH Jr. Alterations in stomach ghrelin production and in ghrelin-induced growth hormone secretion in the aged rat. Mech Ageing Dev. 2004;125:871-875.
30. Mondal MS, Date Y, Yamaguchi H, et al. Identification of ghrelin and its receptor in neurons of the rat arcuate nucleus. Regul Pept. 2005;126:55-59.
31. Willesen MG, Kristensen P, Romer J. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology. 1999;70:306-316.
32. Dickson SL, Luckman SM. Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone, (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. Endocrinology. 1997;138:771-777.
33. Taniguchi S, Yanase T, Kurimoto F, et al. Age-related increase in neuropeptide Y-like immunoreactivity in cerebrospinal fluid in women. Fukuoka Igaku Zasshi. 1994;85:361-365.
34. Pich EM, Messori B, Zoli M, et al. Feeding and drinking responses to neuropeptide Y injections in the paraventricular hypothalamic nucleus of aged rats. Brain Res. 1992;575:265-271.
35. Broberger C, Landry M, Wong H, Walsh J, Hökfelt T. Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology. 1997;66:393-408.
36. Zimanyi IA, Pelleymounter MA. The role of melanocortin peptides and receptors in regulation of energy balance. Curr Pharm Des. 2003;9:627-641.
37. Koylu EO, Couceyro PR, Lambert PD, Ling NC, De Souza EB, Kuhar MJ. Immunohistochemical localization of novel CART peptides in the rat hypothalamus, pituitary and adrenal gland. J Neuroendocrinol. 1997;9:823-833.
38. Lambert PD, Couceyro PR, McGirr KM, Dall Vechia SE, Smith Y, Kuhar MJ. CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse. 1998;29:293-298.
39. Matsumura T, Nakayama M, Nomura A, et al. Age-related changes in plasma orexin-A concentrations. Exp Gerontol. 2002;37:1127-1130.
40. Terao A, Apte-Deshpande A, Morairty S, Freund YR, Kilduff TS. Age-related decline in hypocretin (orexin) receptor 2 messenger RNA levels in the mouse brain. Neurosci Lett. 2002;332:190-194.
41. Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature. 2001;409:194-198.
42. Wolden-Hanson T, Marck BT, Smith L, Matsumoto AM. Cross-sectional and longitudinal analysis of age-associated changes in body composition of male Brown Norway rats: association of serum leptin levels with peripheral adiposity. J Gerontol Biol Sci. 1999;54A: B99-B107.
43. Mizuno T, Bergen H, Kleopoulos S, Bauman WA, Mobbs CV. Effects of nutritional status and aging on leptin gene expression in mice: importance of glucose. Horm Metab Res. 1996;28:679-684.
44. Baumgartner RN, Waters DL, Morley JE, Patrick P, Montoya GD, Garry PJ. Age-related changes in sex hormones affect the sex difference in serum leptin independently of changes in body fat. Metabolism. 1999;48:378-384.
45. Hislop MS, Ratanjee BD, Soule SG, Marais AD. Effects of anabolic-androgenic steroid use or gonadal testosterone suppression on serum leptin concentration in men. Eur J Endocrinol. 1999;141:40-46.
46. Ma XH, Muzumdar R, Yang XM, Gabriely I, Berger R, Barzilai N. Aging is associated with resistance to effects of leptin on fat distribution and insulin action. J Gerontol Biol Sci. 2002;57A:B225-B231.
47. Mann DR, Johnson AO, Gimpel T, Castracane VD. Changes in circulating leptin, leptin receptor, and gonadal hormones from infancy until advanced age in humans. J Clin Endocrinol Metab. 2003;88:3339-3345.
48. Moller N, O'Brien P, Nair KS. Disruption of the relationship between fat content and leptin levels with aging in humans. J Clin Endocrinol Metab. 1998;83:931-934.
49. Toth MJ, Sites CK, Poehlman ET. Hormonal and physiological correlates of energy expenditure and substrate oxidation in middle-aged, premenopausal women. J Clin Endocrinol Metab. 1999;84:2771-2775.
50. Morley JE, Alshaher MM, Farr SA, Flood JF, Kumar VB. Leptin and neuropeptide Y (NPY) modulate nitric oxide synthase: further evidence for a role of nitric oxide in feeding. Peptides. 1999;20:595-600.
51. Capanni C, Squarzoni S, Petrini S, et al. Increase of neuronal nitric oxide synthase in rat skeletal muscle during ageing. Biochem Biophys Res Commun. 1998;245:216-219.
52. Chalimoniuk M, Strosznajder JB. Aging modulates nitric oxide synthesis and cGMP levels in hippocampus and cerebellum. Effects of amyloid beta peptide. Mol Chem Neuropathol. 1998;35:77-95.
53. Morley JE, Kumar VB, Mattammal MB, Farr S, Morley PM, Flood JF. Inhibition of feeding by a nitric oxide synthase inhibitor: effects of aging. Eur J Pharmacol. 1996;311:15-19.
54. Reckelhoff JF, Hennington BS, Kanji V, et al. Chronic aminoguanidine attenuates renal dysfunction and injury in aging rats. Am J Hypertens. 1999;12:492-498.
55. Yamada K, Nabeshima T. Changes in NMDA receptor/nitric oxide signaling pathway in the brain with aging. Microsc Res Tech. 1998;43:68-74.
56. Tan D, Cernadas MR, Aragoncillo P, et al. Role of nitric oxide-related mechanisms in renal function in ageing rats. Nephrol Dial Transplant. 1998;13:594-601.
57. McCann SM, Licinio J, Wong ML, Yu WH, Karanth S, Rettorri V. The nitric oxide hypothesis of aging. Exp Gerontol. 1998;33:813-826.
58. D'Costa AP, Ingram RL, Lenham JE, Sonntag WE. The regulation and mechanisms of action of growth hormone and insulin-like growth factor 1 during normal ageing. J Reprod Fertil Suppl. 1993;46:87-98.
59. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86:5992.